CHARACTERIZATION OF RICE
    1.
    发明申请
    CHARACTERIZATION OF RICE 审中-公开
    稻米特征

    公开(公告)号:US20160213733A1

    公开(公告)日:2016-07-28

    申请号:US15008336

    申请日:2016-01-27

    发明人: Robert James Nash

    摘要: Processes for the production of a composition comprising material derived from seeds of plants of the genus Oryza, the process comprise the steps of: (a) providing material derived from seeds of the genus Oryza; and (b) determining the presence or absence and/or measuring the amount of at least one iminosugar in the material of step (a). Also described is the use of material derived from seeds of plants of the genus Oryza, which material comprises at least one iminosugar, as a food or feed supplement for lowering the glycaemic index (GI) value of said food or feed.

    摘要翻译: 用于生产包含衍生自Oryza植物种子的物质的组合物的方法,该方法包括以下步骤:(a)提供衍生自Oryza属种子的物质; 和(b)确定步骤(a)的材料中存在或不存在和/或测量至少一种亚氨基糖苷的量。 还描述了使用源自Oryza属植物的种子的材料,该材料包含至少一种亚氨基甘露糖,作为用于降低所述食物或饲料的血糖指数(GI)值的食物或饲料补充剂。

    BIOACTIVE PHYTOCHEMICALS IN ZIZYPHUS AND GUARANA

    公开(公告)号:US20210403424A1

    公开(公告)日:2021-12-30

    申请号:US17338422

    申请日:2021-06-03

    发明人: Robert James Nash

    摘要: Described are compositions comprising selected isolated 4-hydroxymethyl-prolines, or pharmaceutically acceptable salts or derivatives thereof. Also described are novel 4-hydroxymethyl-N-methyl-prolines, together with processes for their preparation, compositions containing them, as well as their use as medicaments and pharmaceuticals. Also described are processes for producing a herbal medicine comprising the step of monitoring the quality of said herbal medicine by detecting the presence or absence or measuring the amount of one or more 4-hydroxymethyl-N-methyl-prolines in a sample of said herbal medicine.

    BIOACTIVE PHYTOCHEMICALS
    10.
    发明申请

    公开(公告)号:US20220288049A1

    公开(公告)日:2022-09-15

    申请号:US17584744

    申请日:2022-01-26

    发明人: Robert James Nash

    摘要: Described are processes for the production of a composition comprising (2R, 3R, 4R, 5S)-3, 4, 5-trihydroxypiperidine-2-carboxylic acid (idoBR1), said process comprising the steps of: a) providing plant material from a botanical source comprising plant of the family Cucurbitaceae; b) fractionating said plant material to produce an extract enriched in idoBR1 c) assaying said extract for: i) inhibitory activity against sialidase or TNF-alpha or ii) IL-10 stimulatory activity; and d) formulating said assayed extract with a cosmetically-, nutraceutically- or pharmaceutically-acceptable excipient or carrier to produce a cosmetic, nutraceutical or pharmaceutical composition.